Does ELIQUIS Cause Pulmonary embolism? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Pulmonary embolism have been filed in association with ELIQUIS. This represents 0.8% of all adverse event reports for ELIQUIS.
11
Reports of Pulmonary embolism with ELIQUIS
0.8%
of all ELIQUIS reports
2
Deaths
3
Hospitalizations
How Dangerous Is Pulmonary embolism From ELIQUIS?
Of the 11 reports, 2 (18.2%) resulted in death, 3 (27.3%) required hospitalization, and 3 (27.3%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELIQUIS. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ELIQUIS Cause?
Haemorrhage (79)
Gastrointestinal haemorrhage (72)
Dizziness (65)
Rash (51)
Epistaxis (49)
Headache (49)
Dyspnoea (41)
Adverse event (40)
Diarrhoea (37)
Contusion (34)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which ELIQUIS Alternatives Have Lower Pulmonary embolism Risk?
ELIQUIS vs ELOSULFASE ALFA
ELIQUIS vs ELOTUZUMAB
ELIQUIS vs ELOXATIN
ELIQUIS vs ELRANATAMAB
ELIQUIS vs ELRANATAMAB-BCMM